Advertisement
U.S. Markets close in 3 hrs 32 mins

Glenmark Life Sciences Limited (GLS.NS)

NSE - NSE Real Time Price. Currency in INR
1,045.25-67.65 (-6.08%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 136.17B
Enterprise Value 133.33B
Trailing P/E 30.57
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.22
Price/Book (mrq)5.85
Enterprise Value/Revenue 6.10
Enterprise Value/EBITDA 19.43

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31,335.10
52 Week Low 3611.20
50-Day Moving Average 31,119.07
200-Day Moving Average 3905.89

Share Statistics

Avg Vol (3 month) 3319.1k
Avg Vol (10 day) 3122.76k
Shares Outstanding 5122.53M
Implied Shares Outstanding 6N/A
Float 830.63M
% Held by Insiders 176.43%
% Held by Institutions 14.60%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 443.5
Forward Annual Dividend Yield 43.71%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 461.80%
Dividend Date 3N/A
Ex-Dividend Date 4Oct 17, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 19.49%
Operating Margin (ttm)24.65%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)22.93B
Revenue Per Share (ttm)187.19
Quarterly Revenue Growth (yoy)1.80%
Gross Profit (ttm)N/A
EBITDA 6.43B
Net Income Avi to Common (ttm)4.47B
Diluted EPS (ttm)36.39
Quarterly Earnings Growth (yoy)-17.70%

Balance Sheet

Total Cash (mrq)3.02B
Total Cash Per Share (mrq)24.62
Total Debt (mrq)171.48M
Total Debt/Equity (mrq)0.74
Current Ratio (mrq)N/A
Book Value Per Share (mrq)190.28

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A